IMPACT OF INTERSTITIAL FIBROSIS (IF) BY AUTOMATIC QUANTIFICATION AT ONE YEAR ON THE EVOLUTION OF RENAL FUNCTION IN TRANSPLANT RECIPIENTS WITH CYCLOSPORINE (CSA) DISCONTINUATION AND SIROLIMUS (SRL) INTRODUCTION

被引:0
|
作者
Servais, Aude [1 ,2 ]
Meas-Yedid, Vannary [3 ]
Toupance, Olivier [4 ]
Lebranchu, Yvon [5 ]
Touchard, Guy [6 ]
Westeel, Pierre Francois [7 ]
Etienne, Isabelle [8 ]
Moulin, Bruno [9 ]
de Ligny, Bruno Hurault [10 ]
Le Pogamp, Patrick [11 ]
Hayem, Cecile [12 ]
Marin, Jean Christophe Olivo [3 ]
Thervet, Eric [1 ,2 ]
机构
[1] Hop Necker Enfants Malad, Paris, France
[2] Univ Paris 05, Paris, France
[3] Inst Pasteur, Paris, France
[4] CHU, Reims, France
[5] CHU Tours, Tours, France
[6] CHU, Poitiers, France
[7] CHU, Amiens, France
[8] CHU, Rouen, France
[9] CHU Strasbourg, F-67000 Strasbourg, France
[10] CHU Caen, F-14000 Caen, France
[11] CHU, Rennes, France
[12] Roche, Med, Neuilly sur Seine, France
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:174 / 174
页数:1
相关论文
共 18 条
  • [1] Comparison at one year of interstitial fibrosis (IF) by automatic quantification in renal transplant recipients with cyclosporine (CsA) discontinuation and sirolimus (SRL) introduction
    Servais, Aude
    Meas-Yedid, Vannary
    Lebranchu, Yvon
    Etienne, Isabelle
    Touchard, Guy
    Legendre, Christophe
    Westeel, Pierre Francois
    Toupance, Olivier
    de Ligny, Bruno Hurault
    Olivo-Marin, Christophe
    Thervet, Eric
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 319 - 319
  • [2] Impact of Interstitial Fibrosis (IF) by Automatic Quantification at One Year on the Evolution of Renal Function in Transplant Recipients with Cyclosporine Discontinuation and Sirolimus Introduction.
    Servais, Aude
    Meas-Yedid, Vannary
    Toupance, Olivier
    Lebranchu, Yvon
    Touchard, Guy
    Westeel, Pierre Francois
    Etienne, Isabelle
    Moulin, Bruno
    de Ligny, Bruno Hurault
    Frouget, Thierry
    Hayem, Cecile
    Olivo-Marin, Christophe
    Thervet, Eric
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 502 - 502
  • [3] Interstitial Fibrosis Quantification in Renal Transplant Recipients Randomized to Continue Cyclosporine or Convert to Sirolimus
    Servais, A.
    Meas-Yedid, V.
    Toupance, O.
    Lebranchu, Y.
    Thierry, A.
    Moulin, B.
    Etienne, I.
    Presne, C.
    Hurault, de Ligny B.
    Le Pogamp, P.
    Le Meur, Y.
    Glotz, D.
    Hayem, C.
    Marin, J. C. Olivo
    Thervet, E.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (11) : 2552 - 2560
  • [4] Comparison of efficacy and safety of cyclosporine (CsA) discontinuation with introduction of sirolimus (SRL) at week 12 to standard strategy in renal transplant recipients receiving mycophenolate mofetil (MMF).
    Lebranchu, Y.
    Etienne, I.
    Touchard, G.
    Thervet, E.
    Westeel, P. F.
    Toupance, O.
    de Ligny, B. Hurault
    Moulin, B.
    Frouget, T.
    Le Meur, Y.
    Glotz, D.
    Mignon, F.
    Deteix, P.
    Subra, J. F.
    Bayle, F.
    Noel, C.
    Hayem, C.
    Girardot-Seguin, S.
    Buehler, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 160 - 160
  • [5] Sirolimus (SRL) maintenance therapy after early cyclosporine (CSA) withdrawal benefits renal transplant recipients with risk factors for reduced renal function: 5-year results
    Russ, G
    Eris, J
    Hutchison, B
    Walker, R
    Chapman, J
    Pussell, B
    Mahoney, J
    Campbell, S
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2006, 84 (03): : A19 - A19
  • [6] Full or 80% Reduced Cyclosporine (CsA) Exposure Improves 1 but Not 10 or 5 Year Renal Transplant Outcomes with Sirolimus (SRL) Base Therapy
    Pliszczynski, Jacek
    Abraham, Jose Benito A.
    Schoenberg, Linda
    Kahan, Barry D.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 507 - 507
  • [7] Incidence of Delayed Graft Function (DGF) in a Sirolimus (SRL)-Based Versus Cyclosporine (CsA)-Based Regimen in De Novo Renal Allograft Recipients.
    Flechner, Stuart M.
    Gurkan, Alihan
    Tai, Sandi See
    Schulman, Seth L.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 278 - 278
  • [8] Impact on renal function in kidney transplant recipients with cyclosporine/tacrolimus toxicity after conversion to sirolimus.
    Kashif, WU
    Hariharan, S
    Siddiqi, NA
    Bresnahan, BP
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 771A - 772A
  • [9] Improved renal function with cyclosporine a (CsA) low dose in everolimus-treated renal transplant pediatric recipients: 1 year results.
    Sanchez-Rodriguez, Teresa
    Covarrubias, Marco
    Solano, Eduardo
    Canchola, Guadalupe
    Rodriguez-Sancho, Luis
    [J]. PEDIATRIC TRANSPLANTATION, 2007, 11 : 71 - 71
  • [10] Improvement of renal function in transplant patients with chronic calcineurin-inhibitor (CNI) nephrotoxicity one year after conversion to Sirolimus (SRL): Predictive value of proteinuria.
    Diekmann, F
    Budde, K
    Oppenheimer, F
    Fritsche, L
    Neumayer, HH
    Campistol, JM
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 648A - 648A